Studies in mice demonstrated that GPIbα is an important mediator of ischemic stroke, suggesting that targeted inhibition of this receptor may open new approaches for stroke treatment (78), especially in view of the thromboinflammatory axis played by VWF-GPIbα interaction in acute ischemic stroke (79). Here, GP1BA is linked to stroke disorder.